Threshold Cancer Drug May Successfully Target Hypoxia
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
In combination with gemcitabine, TH-302 produced positive Phase IIb results in treatment naïve pancreatic cancer patients, according to late-breaking data presented April 2 at the AACR meeting in Chicago.